Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis

Bowman, Tammy, Broome, Martin A., Sinibaldi, Dominic, Wharton, Walker, Pledger, W. J., Sedivy, John M., Irby, Rosalyn, Yeatman, Timothy, Courtneidge, Sara A., Jove, Richard·2001·Proceedings of the National Academy of Sciences
DOI 10.1073/pnas.131568898

Cited by (486)

Items 301–400 of 486

  1. Inhibition of STAT3 by RNA interference suppresses angiogenesis in colorectal carcinoma
    Wenwei Qian, Wenxian Guan, Yong Gao, Jingxue Tan, Zhiming Qiao, Huaxing Huang, C.L. Xia · 2011 · Brazilian Journal of Medical and Biological Research
  2. miR205 inhibits stem cell renewal in SUM159PT breast cancer cells
    Víctor Mayoral-Varo, Annarica Calcabrini, María Pilar Sánchez-Bailón, Jorge Martı́n-Pérez · 2017 · PLoS ONE
  3. Dasatinib synergizes with JSI-124 to inhibit growth and migration and induce apoptosis of malignant human glioma cells
    Ian F. Pollack, Daniel R. Premkumar, Esther P. Jane, Naomi R. Agostino, Joseph L. Scialabba · 2010 · Journal of Carcinogenesis
  4. Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter
    Sara Molenda, Agata Sikorska, Anna Florczak, Patryk Lorenc, Hanna Dams‐Kozlowska · 2023 · Cancers
  5. Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma
    Ming-Hung Hu, Li-Ju Chen, Yen‐Lin Chen, Ming-Shen Tsai, Chung‐Wai Shiau, Tzu-I Chao, Chun‐Yu Liu, Jia‐Horng Kao, Kuen‐Feng Chen · 2017 · Oncotarget
  6. Innate immune cells for immunotherapy of autoimmune and cancer disorders
    Carolina Schäfer, Gabriel Ascui, Carolina Hager Ribeiro, Mercedes Natalia López, Rafael Prados‐Rosales, Pablo A. González, Susan M. Bueno, Claudia A. Riedel, Andrés Baena, Alexis M. Kalergis et al. · 2017 · International Reviews of Immunology
  7. Development of a STAT3 reporter prostate cancer cell line for high throughput screening of STAT3 activators and inhibitors
    My N. Chau, Partha P. Banerjee · 2008 · Biochemical and Biophysical Research Communications
  8. The Reed-Steinberg cell: molecular characterization by proteomic analysis with therapeutic implications.
    Robert Eldon Brown, R Kamal Nazmi · 2002 · PubMed
  9. Clinical significance of Src expression and activity in human neoplasia.
    Nikolaos A. Chatzizacharias, Gregory P. Kouraklis, Constantinos Giaginis, Stamatios E Theocharis · 2012 · PubMed
  10. Contribution of phosphoproteomics in understanding SRC signaling in normal and tumor cells
    Audrey Sirvent, Serge Urbach, Serge Roche · 2014 · PROTEOMICS
  11. c-Myc and EBV–LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells
    Christiane Silke Tudor, William O. Dawson, Jenny Eckhardt, Gerald Niedobitek, Anke Caroline Büttner, Barbara Seliger, Arndt Hartmann, Maike Julia Buettner · 2012 · British Journal of Cancer
  12. Malignant transformation of an epithelial cell by v-Src via tv-a-mediated retroviral infection: A new cell model for studying carcinogenesis
    Shu‐Ling Fu, Yu-Jing Huang, Fong-Pin Liang, Yung‐Fen Huang, Ching-Feng Chuang, Shih‐Wei Wang, Ju-Wen Yao · 2005 · Biochemical and Biophysical Research Communications
  13. Selective transcription and cellular proliferation induced by PDGF require histone deacetylase activity
    Annunziata Catania, Carlo Iavarone, Stella M. Carlomagno, Mario Chiariello · 2006 · Biochemical and Biophysical Research Communications
  14. STAT3 expression in salivary gland tumours
    Vera Cavalcanti de Araújo, Cristiane Furuse, Patrícia Ramos Cury, ALBINA MESSIAS DE ALMEIDA MILANI ALTEMANI, Ney Soares de Araújo · 2007 · Oral Oncology
  15. Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity
    Katja Linher‐Melville, Mina G. Nashed, Robert G. Ungard, Sina Haftchenary, David A. Rosa, Patrick Thomas Gunning, Gurmit Singh · 2016 · PLoS ONE
  16. Synthesis, structure–activity relationships and stereochemical investigations of new tricyclic pyridazinone derivatives as potential STAT3 inhibitors
    D. Masciocchi, Arianna Gelain, Federica Porta, Fiorella Meneghetti, Alessandro Pedretti, Giuseppe Celentano, Daniela Barlocco, Laura Legnani, Lucio Toma, Byoung‐Mog Kwon et al. · 2013 · MedChemComm
  17. STAT3 activation in HER2 ‐positive breast cancers: Analysis of data from a large prospective trial
    Amir Sonnenblick, Dominique Agbor‐Tarh, Evandro de Azambuja, Susanne Hultsch, Miguel Angel Izquierdo, MC Liu, Giancarlo Pruneri, Nadia Harbeck, Martine J Piccart, Alvaro Moreno‐Aspita et al. · 2020 · International Journal of Cancer
  18. Basal STAT3 activities are negatively correlated with tumor size in papillary thyroid carcinomas.
    Won Gu Kim, H-J Choi, Won Bae Kim, Eun‐Sung Kim, J H Yim, Tae Yong Kim, Gyungyub Gong, Su‐Young Kim, Namhyun Chung, Young Kee Shong · 2012 · PubMed
  19. CRY1Regulates Chemoresistance in Association WithNANOGby Inhibiting Apoptosisvia STAT3Pathway in Patients With Cervical Cancer
    Gwan Hee Han, Julie J. Kim, Hee Yun, Hanbyoul Cho, Joon‐Yong Chung, Jae‐Hoon Kim, Stephen M. Hewitt · 2021 · Cancer Genomics & Proteomics
  20. Targeting c-Myc Unbalances UPR towards Cell Death and Impairs DDR in Lymphoma and Multiple Myeloma Cells
    Andrea Arena, Maria Anele Romeo, Rossella Benedetti, Maria Saveria Gilardini Montani, Mara Cirone · 2022 · Biomedicines
  21. Regulation of Src tumor activity by its N-terminal intrinsically disordered region
    Emilie Aponte, Marie Lafitte, Audrey Sirvent, Valérie Simon, Maud Barbery, Elise Fourgous, Yvan Boublik, Mariano Maffei, Florence Armand, Romain Hamelin et al. · 2022 · Oncogene
  22. The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma
    Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli, Jessica Faletti, Davide Capoferri, Raffaella Marcheselli, Margherita Sciumé, Marco Presta, Antonio Sacco, Aldo Maria Roccaro · 2024 · Journal of Experimental & Clinical Cancer Research
  23. A Specific Epitope of Protein Inhibitor of Activated STAT3 Is Responsible for the Induction of Apoptosis in Rat Transformed Mast Cells
    Zohar Yagil, Gillian Kay, Hovav Nechushtan, Ehud Razin · 2009 · The Journal of Immunology
  24. Molecular mechanisms involved in angiogenesis and potential target of antiangiogenesis in human glioblastomas
    Baohui Liu, Yang Xu, Fanen Yuan, Qianxue Chen · 2018 · Glioma
  25. Blockade of PDGFRβ circumvents resistance to MEK-JAK inhibition via intratumoral CD8+ T-cells infiltration in triple-negative breast cancer
    Murugan Kalimutho, Debottam Sinha, Deepak Mittal, Sriganesh Srihari, Devathri M. Nanayakkara, Shagufta Shafique, Prahlad V. Raninga, Purba Nag, Kate Parsons, Kum Kum Khanna · 2019 · Journal of Experimental & Clinical Cancer Research
  26. PDCD2 Controls Hematopoietic Stem Cell Differentiation During Development
    Joseph Kramer, Celine J. Granier, Stephani A. Davis, Katherine Piso, Jane Hand, Arnold B. Rabson, Hatem E. Sabaawy · 2012 · Stem Cells and Development
  27. Silencing STAT3 with short hairpin RNA enhances radiosensitivity of human laryngeal squamous cell carcinoma xenografts in vivo
    Xiaoming Li, Hairu Wang, Xiuying Lu, Bin Di · 2010 · Experimental and Therapeutic Medicine
  28. Signal transducer and activator of transcription 1 (Stat1) maintains basal mRNA expression of pro-survival stat3-target genes in glioma C6 cells
    Alicja Adach, Karolina Swiatek-Machado, Bozena Kaminska, Michał Dąbrowski · 2011 · Journal of Cellular Biochemistry
  29. Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC
    Mingzhu Li, Lina Duan, Wenjie Wu, Wenjing Li, Lili Zhao, Ang Li, Xuebo Lu, Xinyu He, Zigang Dong, Kangdong Liu et al. · 2023 · Oncogenesis
  30. Efficient inhibition of intraperitoneal ovarian cancer growth in nude mice by liposomal delivery of short hairpin RNA against STAT 3
    Qingyuan Jiang, Lei Dai, Lin Cheng, Xiaolei Chen, Yiming Li, Shuang Zhang, Xiaolan Su, Xia Zhao, Yuquan Wei, Hongxin Deng · 2012 · Journal of obstetrics and gynaecology research
  31. Integration of genome-wide of Stat3 binding and epigenetic modification mapping with transcriptome reveals novel Stat3 target genes in glioma cells
    Marcin Kruczyk, Piotr Przanowski, Michał Dąbrowski, Karolina Swiatek-Machado, Jakub Mieczkowski, Ola Wallerman, Anna Ronowicz, Arkadiusz Piotrowski, Claes Wadelius, Bozena Kaminska et al. · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  32. Differential Effect of the Focal Adhesion Kinase Y397F Mutant on v-Src-Stimulated Cell Invasion and Tumor Growth
    Liang-Chen Chang, Chi-Hui Huang, Chi-Hung Cheng, Bor-Huah Chen, Hong‐Chen Chen · 2005 · Journal of Biomedical Science
  33. The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme
    Richard Martin Bambury, Patrick Glyn Morris · 2014 · Expert Review of Anticancer Therapy
  34. Src Kinase and Pancreatic Cancer
    Andreas Hilbig · 2007 · Springer eBooks
  35. Functional analysis of cancer-associated germline risk variants
    Laura N. Kellman, Poornima H. Neela, Suhas Srinivasan, Zurab Siprashvili, Ronald L. Shanderson, Audrey W. Hong, Deepti S. Rao, Douglas F. Porter, David L. Reynolds, Robin M. Meyers et al. · 2025 · Nature Genetics
  36. Deregulation of miRNAs-cMYC circuits is a key event in refractory celiac disease type-2 lymphomagenesis
    Valentina Vaira, Gabriella Gaudioso, Maria Antonella Laginestra, Andrea Terrasi, Claudio Agostinelli, Silvano Bòsari, Antonio Di Sabatino, Alessandro Vanoli, Marco Paulli, Stefano Ferrero et al. · 2020 · Clinical Science
  37. Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3
    Hong Yue, Kuniyoshi Tanaka, Tatsuhiko Furukawa, Sadashiva S. Karnik, Wěi Li · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  38. Src kinase induces tumor formation in the c‐SRC C57BL/6 mouse
    Christina Leah B. Kline, Rosalind J. Jackson, Robert W. Engelman, Warren Jack Pledger, Timothy Joseph Yeatman, Rosalyn Irby · 2008 · International Journal of Cancer
  39. Activation of STAT3 signaling in human stomach adenocarcinoma drug-resistant cell line and its relationship with expression of vascular endothelial growth factor
    Li-Fen Yu · 2005 · World Journal of Gastroenterology
  40. RAI14 silencing suppresses progression of esophageal cancer via the STAT3 pathway
    Jianlin Wang, Yun Cai, Judong Luo, Zhiqiang Sun, Jingping Yu, Feng Yan, Xia He · 2020 · Aging
  41. Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth
    Cecilia Jazmín Proietti, Franco Izzo, María C. Díaz Flaqué, Rosalía I. Cordo Russo, Leandro Venturutti, Maria Florencia Mercogliano, Mara De Martino, Viviana Pineda, Sergio Muñoz, Pablo Guzmán et al. · 2015 · Molecular Endocrinology
  42. Immunological Trigger of Mast Cells by Monomeric IgE: Effect on Microphthalmia Transcription Factor, STAT3 Network of Interactions
    Amir Sonnenblick, Carmit Levy, Ehud Razin · 2005 · The Journal of Immunology
  43. Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression
    Baoying Hu, Yan Xia, Fang Liu, Changlai Zhu, Huiling Zhou, Yuyan Chen, Jinxia Liu, Xingxing Gu, Runzhou Ni, Tianyi Zhang · 2015 · Pathology & Oncology Research
  44. Paradoxical role of phosphorylated STAT3 in normal fertility and the pathogenesis of adenomyosis and endometriosis
    Yichi Xu, Fan Wu, Chuanmei Qin, Yi Lin · 2023 · Biology of Reproduction
  45. Homoharringtonine: mechanisms, clinical applications and research progress
    Wen Wang, Lan He, Ting Lin, Fulan Xiang, Yibin Wu, Fangliang Zhou, Yingchun He · 2025 · Frontiers in Oncology
  46. Immunohistochemical Study of STAT3 Expression in Feline Injection-site Fibrosarcomas
    Claudio Petterino, Marina Martano, Paolo Cascio, Fulvia Cerruti, Marco Martini, Emanuela Maria Morello, Raffaele Bruno, Massimo Castagnaro, Paolo Buracco · 2006 · Journal of Comparative Pathology
  47. S ignal T ransducers and A ctivators of T ranscription: I nsights into the M olecular B asis of O ral C ancer
    Hessam Siavash, Nikolaos G. Nikitakis, John J. Sauk · 2004 · Critical Reviews in Oral Biology & Medicine
  48. Cyclin E and cyclin A are likely targets of Src for PDGF‐induced DNA synthesis in fibroblasts
    Furstoss, Olivia, Manes, Gaël, Roche, Serge · 2002 · FEBS Letters
  49. Identification of Homoharringtonine as a potent inhibitor of glioblastoma cell proliferation and migration
    Elena Porcù, Francesca Maule, Lorenzo Manfreda, Elena Mariotto, Silvia Bresolin, Alice Cani, Roberta Bortolozzi, Alessandro Della Puppa, Diana Corallo, Giampietro Viola et al. · 2022 · Translational research
  50. Natural bioactive compounds and STAT3 against hepatocellular carcinoma: An update
    Suryaa Manoharan, Shreejit Saha, Krishnasanthiya Murugesan, Aksayakeerthana Santhakumar, Ekambaram Perumal · 2023 · Life Sciences
  51. IL-21 Stimulates the expression and activation of cell cycle regulators and promotes cell proliferation in EBV-positive diffuse large B cell lymphoma
    Yuxuan Wang, Chengcheng Wang, Xiyunyi Cai, Chang Mou, Xueting Cui, Yingying Zhang, Feng Ge, Hao Dong, Yuanyuan Hao, Lei Cai et al. · 2020 · Scientific Reports
  52. Curcumin modulates airway remodelling‐contributing genes—the significance of transcription factors
    Joanna Wieczfińska, Przemysław Sitarek, Tomasz Kowalczyk, Piotr Rieske, Rafał Pawliczak · 2021 · Journal of Cellular and Molecular Medicine
  53. Supernumerary Isochromosome 1, idic(1)(p12), Leading to Tetrasomy 1q in Burkitt Lymphoma
    Anne Stidsholt Roug, P. Wendtland, Knud Bendix, Eigil Kjeldsen · 2013 · Cytogenetic and Genome Research
  54. Chemical modulation of transcription factors
    Bianca M. Wiedemann, Jörn Weisner, Daniel Rauh · 2018 · MedChemComm
  55. Screening of Stat3 inhibitory effects of Korean herbal medicines in the A549 human lung cancer cell line
    Jong-Shik Park, Ok‐Sun Bang, Jinhee Kim · 2013 · Integrative Medicine Research
  56. Alterations of oncogenes expression in NK cells in patients with cancer
    Gulnur K. Zakiryanova, Елена Анатольевна Кустова, Nataliya T. Urazalieva, Aday Amirbekov, Emile T. Baimuchametov, Narymzhan N. Nakisbekov, Michael R. Shurin · 2017 · Immunity Inflammation and Disease
  57. The rGel/BLyS fusion toxin inhibits STAT3 signaling via down-regulation of interleukin-6 receptor in diffuse large B-cell lymphoma
    Mi-Ae Lyu, Bokyung Sung, Lawrence H. Cheung, John W. Marks, Bharat Bhushan Aggarwal, Ricardo C.T. Aguiar, Michael G. Rosenblum · 2010 · Biochemical Pharmacology
  58. Ureido‐Pyridazinone Derivatives: Insights into the Structural and Conformational Properties for STAT3 Inhibition
    Fiorella Meneghetti, Stefania Villa, D. Masciocchi, Daniela Barlocco, Lucio Toma, Dong‐Cho Han, Byoung‐Mog Kwon, Naohisa Ogo, Akira Asai, Laura Legnani et al. · 2015 · European Journal of Organic Chemistry
  59. Murrayafoline A Induces a G0/G1-Phase Arrest in Platelet-Derived Growth Factor-Stimulated Vascular Smooth Muscle Cells
    Joo‐Hui Han, Yohan Kim, Sang-Hyuk Jung, Jung-Jin Lee, Hyun-Soo Park, Gyu-Yong Song, Nguyễn Mạnh Cường, Young Ho Kim, Chang‐Seon Myung · 2015 · Korean Journal of Physiology and Pharmacology
  60. Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer
    Sultan Alhayyani, Louise McLeod, Alison C. West, Jesse J. Balic, Christopher Hodges, Liang Yu, Julian Anderson Smith, Zdenka Prodanovic, Steven Bozinovski, Beena Kumar et al. · 2021 · Oncogene
  61. Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers
    Laura Vízkeleti, Sándor Spisák · 2023 · Cells
  62. Inhibitory effect of a novel naphthoquinone derivative on proliferation of vascular smooth muscle cells through suppression of platelet-derived growth factor receptor β tyrosine kinase
    Yohan Kim, Joo‐Hui Han, Eunju Yun, Sang‐Hyuk Jung, Jung‐Jin Lee, Gyu‐Yong Song, Chang‐Seon Myung · 2014 · European Journal of Pharmacology
  63. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity☆
    Jennifer Dourlat, Wang‐Qing Liu, Florence Sancier, Thomas Edmonds, Perayot Pamonsinlapatham, Francisco H. Cruzalegui, Christiane Garbay · 2009 · Biochimie
  64. Signal transducer and activator of transcription‐3 expression and activation is dysregulated in actinic cheilitis
    Patrícia Ramos Cury, Cristiane Furuse, Ney Soares de Araújo, Vera Cavalcanti de Araújo · 2006 · Journal of Cutaneous Pathology
  65. STAT and SMAD signaling in cancer.
    Takashi Iwamoto, K Oshima, Tzer Jing Seng, Xin‐Hua Feng, Myat Lin Oo, Michinari Hamaguchi, Satoru Matsuda · 2002 · PubMed
  66. ARHGEF4 predicts poor prognosis and promotes cell invasion by influencing ERK1/2 and GSK-3α/β signaling in pancreatic cancer
    Keisuke Taniuchi, Mutsuo Furihata, Seiji Naganuma, Toshiji Saibara · 2018 · International Journal of Oncology
  67. Peptide modulators of Src activity in G1 regulate entry into S phase and proliferation of NIH 3T3 cells
    Vidya Mamidipudi, Laura D. Miller, Daria Mochly‐Rosen, Christine A. Cartwright · 2006 · Biochemical and Biophysical Research Communications
  68. Major Functional Transcriptome of an Inferred Center Regulator of an ER(–) Breast Cancer Model System
    Li-Yu Daisy Liu, Li‐Yun Chang, Wen‐Hung Kuo, Hsiao‐Lin Hwa, Yi-Shing Lin, Shiu-Feng Kathy Huang, Chiung‐Nien Chen, King‐Jen Chang, Fon‐Jou Hsieh · 2012 · Cancer Informatics
  69. Resistance to Antiangiogenic Therapies
    Marco Bartolotti, Enrico Franceschi, Rosalba Poggi, Alicia Tosoni, Monica Di Battista, Alba Ariela Brandes · 2014 · Future Oncology
  70. The simian virus 40 large tumor antigen activates cSrc and requires cSrc for full neoplastic transformation.
    Rozanne Arulanandam, Mulu Geletu, Leda H. Raptis · 2010 · PubMed
  71. Catalytically inactive SHIP2 inhibits proliferation by attenuating pdgf signaling in 3T3‐L1 preadipocytes
    Yulia Artemenko, AnneMarie Gagnon, Alexander Sorisky · 2008 · Journal of Cellular Physiology
  72. Terpenes
    Christophe Wiart · 2012 · Elsevier eBooks
  73. Delivery of interferons and siRNA targeting STAT3 using lentiviral vectors suppresses the growth of murine melanoma
    X Wang, Peng Liu, H Liu, Wancai Yang, Z Liu, Z Zhuo, Y. Gao · 2012 · Cancer Gene Therapy
  74. Targeting the mercapturic acid pathway for the treatment of melanoma
    Sharad S. Singhal, Saumya Srivastava, Tamara Mirzapoiazova, David A. Horne, Sanjay Awasthi, Ravi Salgia · 2021 · Cancer Letters
  75. 5,8-Dimethoxy-2-Nonylamino-Naphthalene-1,4-Dione Inhibits Vascular Smooth Muscle Cell Proliferation by Blocking Autophosphorylation of PDGF-Receptor β
    Yohan Kim, Jung‐Jin Lee, Sang-Gil Lee, Sang‐Hyuk Jung, Joo‐Hui Han, So Young Yang, Eunju Yun, Gyu‐Yong Song, Chang‐Seon Myung · 2013 · Korean Journal of Physiology and Pharmacology
  76. Leukocyte-reduced platelet-rich plasma stimulates the in vitro proliferation of adipose-tissue derived mesenchymal stem cells depending on PDGF signaling
    Siegmund Lang, Marietta Herrmann, Christian Pfeifer, Gero Brockhoff, Johannes Zellner, Michael L. Nerlich, Peter Angele, Lukas Prantl, Sebastian Gehmert, Markus Loibl · 2017 · Clinical Hemorheology and Microcirculation
  77. Herpesvirus saimiri STP A11 protein interacts with STAT3 and stimulates its transcriptional activity
    Junsoo Park, Taegun Seo, Jun Yeong Jung, Joonho Choe · 2004 · Biochemical and Biophysical Research Communications
  78. AG490 inhibits G1-S traverse in BALB/c-3T3 cells following either mitogenic stimulation or exogenous expression of E2F-1
    Jason G. Savell, Yihong Ma, Kristin S. Morrow, Richard Jove, Nancy Olashaw, Pope Lloyd Moseley, William Douglas Cress, Walker Wharton · 2004 · Molecular Cancer Therapeutics
  79. Blockade of v‐Src‐stimulated tumor formation by the Src homology 3 domain of Crk‐associated substrate (Cas)
    Chi-Hung Cheng, Kuo-Ching Yu, Hsin-Ling Chen, Shu-Yi Chen, Chi-Hui Huang, Po-Chao Chan, Chiung-Wha Wung, Hong‐Chen Chen · 2003 · FEBS Letters
  80. STAT3 potentiates RNA polymerase I-directed transcription and tumor growth by activating RPA34 expression
    Cheng Zhang, Juan Wang, Xiaoye Song, Deen Yu, Baoqiang Guo, Yaoyu Pang, Xiaomei Yin, Shasha Zhao, Huan Deng, Shihua Zhang et al. · 2022 · British Journal of Cancer
  81. STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo
    Kyle Rohrer, Heyu Song, Anum Akbar, Yingling Chen, Suravi Pramanik, Phillip J. Wilder, Erin M. McIntyre, Nagendra K. Chaturvedi, Kishor K. Bhakat, Angie Rizzino et al. · 2023 · Cancers
  82. Stachydrine is effective and selective against blast phase chronic myeloid leukaemia through inhibition of multiple receptor tyrosine kinases
    Ruixin Gu, Wei Zhang, Dandan Xu · 2022 · Pharmaceutical Biology
  83. Clinical Relevance of Targeted Interference with Src-Mediated Signal Transduction Events
    Quan P. Ly, Timothy Joseph Yeatman · 2007 · Springer eBooks
  84. The role of SRC family kinases in prostate cancer.
    Oleg Tatarov, Joanne Edwards · 2007 · Europe PMC (PubMed Central)
  85. KMT2A and chronic inflammation as potential drivers of sporadic parathyroid adenoma
    Qin Xu, Ting La, Kaihong Ye, Li Wang, Shasha Wang, Yifeng Hu, Liu Teng, Lei Yan, Jinming Li, Zhenhua Zhang et al. · 2024 · Clinical and Translational Medicine
  86. Systematic understanding of the potential targets and pharmacological mechanisms of acteoside by network pharmacology approach
    Yiliyasi Aisa, Kurexi Yunusi, Qian Chen, Na Mi · 2020 · Medicinal Chemistry Research
  87. Therapeutic potential of vasculogenic mimicry in urological tumors
    Xinyu Lin, Sheng Long, Congcong Yan, Xiaofeng Zou, Guoxi Zhang, Junrong Zou, Gengqing Wu · 2023 · Frontiers in Oncology
  88. VPS35/Retromer-dependent MT1-MMP regulation confers melanoma metastasis
    Qinggang Hao, Yan Bai, Ruiqi Guan, Rui Dong, Weiyu Bai, Hayam Hamdy, Liqiong Wang, Mingyao Meng, Yan Sun, Junling Shen et al. · 2025 · Science China Life Sciences
  89. Vitamin D against diabetic adipose tissue inflammation through SHP-1/STAT3 pathway
    Xiaonuo Wei, Yulin Wang, Wenyi Liu, Dongdong Zhang, Chunyu Zhou, Zhongyan Jiang, Wenjie Li, Xing Li, Yufan Miao · 2025 · International Immunopharmacology
  90. Taraxacum spp. in vitro and in vivo anticancer activity – A review
    Ana Isabel Oliveira, Cláudia Pinho, Filipa Quintela Vieira, Regina Augusta Silva, Agostinho Cruz · 2022 · Journal of Herbal Medicine
  91. Transcription Factors STAT3 and MYC Are Key Players of Human Platelet Lysate-Induced Cell Proliferation
    Michaela Oeller, Heidi Jaksch‐Bogensperger, Markus F. Templin, Renate Gehwolf, Eva Rohde, Katharina Schallmoser, Sandra Laner‐Plamberger · 2022 · International Journal of Molecular Sciences
  92. HSP110 Inhibition in Primary Effusion Lymphoma Cells: One Molecule, Many Pro-Survival Targets
    Roberta Gonnella, Roberta Zarrella, Michele Di Crosta, Rossella Benedetti, Andrea Arena, Roberta Santarelli, Maria Saveria Gilardini Montani, Gabriella D’Orazi, Mara Cirone · 2023 · Cancers
  93. Signaling Chains
    Marie-Hélène Teiten, Romain Blasius, Franck Morceau, Marc F. Diederich, Mario A. Dicato · 2007 · Elsevier eBooks
  94. Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of “germinotropic” lymphoproliferative disorder
    Luisa Lorenzi, Silvia Lonardi, Murad Essatari, Vilma Pellegrini, Simona Fisogni, Anna Gazzola, Claudio Agostinelli, William Vermi, Giuseppe Rossi, Giovannino Massarelli et al. · 2016 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  95. Evaluation of the STAT3 inhibitor GLG‑302 for the prevention of estrogen receptor‑positive and ‑negative mammary cancers
    Robert H. Shoemaker, Jennifer T. Fox, M. Margaret Juliana, Fariba L. Moeinpour, Clinton J. Grubbs · 2019 · Oncology Reports
  96. Regulation of HC11 mouse breast epithelial cell differentiation by the E-cadherin/Rac axis
    Maximilian Niit, Rozanne Arulanandam, Jamaica Cass, Mulu Geletu, Victoria Hoskin, Graham P. Côté, Patrick Thomas Gunning, Bruce E. Elliott, Leda H. Raptis · 2017 · Experimental Cell Research
  97. The role played by key transcription factors in activated mast cells
    Irit Carmi-Levy, Ehud Razin · 2007 · Immunological Reviews
  98. Interactions of STATs with Src Family Kinases
    Corinne M. Silva, Julie L. Boerner, Sarah J. Parsons · 2003 · Springer eBooks
  99. Src activation decouples cell division orientation from cell geometry in mammalian cells
    Xiaoyan Sun, Hongsheng Qi, Xiuzhen Zhang, Li Li, Jiaping Zhang, Qunli Zeng, George S. Laszlo, Bo Wei, Tianhong Li, Jianxin Jiang et al. · 2018 · Biomaterials
  100. Tumor microenvironment in a minipig model of spinal cord glioma
    Muhibullah S. Tora, Stewart G. Neill, Yuliya Lakhina, Hemza Assed, Michelle H. Zhang, Purva P. Nagarajan, Thais Federici, Juanmarco Gutierrez, Kimberly Bojanowski Hoang, Yuhong Du et al. · 2023 · Journal of Translational Medicine